DRUG SAFETY:
FDA Panel Urges Caution on Many Anti-Inflammatory Drugs
Jennifer Couzin
GAITHERSBURG, MARYLAND--At a 3-day meeting last week to hash out how a class of painkillers might trigger heart attacks and strokes, new puzzles emerged, even as two U.S. Food and Drug Administration (FDA) advisory committees agreed that use of the drugs be allowed but sharply curtailed.